ResMed | RMD - Net Income

Stock Price
42.39
Daily Change
0.47 1.12%
Monthly
-2.57%
Yearly
14.54%
Q3 Forecast
42.03

ResMed reported $379.7M in Net Income for its fiscal quarter ending in June of 2025.



Financials
Stock Price USD
Assets USD 8.17B
Cash and Equivalent USD 1.21B
Cost of Sales USD 518.56M
Current Assets USD 3.51B
Current Liabilities USD 1.02B
Debt USD 851.81M
Dividend Yield USD 0.82
EBIT USD 456.57M
EBITDA USD 530.86M
Employees USD 8.16K
EPS Earnings Per Share USD 2.58
Equity Capital and Reserves USD 5.97B
Gross Profit on Sales USD 829.44M
Interest Expense on Debt USD 775K
Interest Income USD 59K
Loan Capital USD 658.39M
Market Capitalization USD 43.89B
Net Income USD 379.7M
Operating Expenses USD 891.42M
Operating Profit USD 456.57M
Ordinary Share Capital USD 146.39M
PE Price to Earnings USD 28.85
Pre-Tax Profit USD 458.05M
Sales Revenues USD 1.35B
Selling and Administration Expenses USD 265.12M
Stock USD 975.96M
Trade Creditors USD 278.16M
Trade Debtors USD 990.67M

Net Income Change Date
Ansell USD 57.1M 37.7M Jun/2024
Avita Medical AUD -11589000 3.8M Dec/2024
Cochlear AUD 205.1M 39.7M Dec/2024
CSL USD 2.01B 1.27B Dec/2024
Fisher & Paykel Healthcare NZD 377.2M 224M Mar/2025
Healius AUD -12800000 7.8M Dec/2024
Integral Diagnostics AUD 6.06M 72.81M Jun/2024
Mayne Pharma AUD -103681000 68.4M Jun/2024
Nanosonics AUD 9.76M 6.36M Dec/2024
Polynovo AUD 1.28M 1.41M Jun/2024
Ramsay Health Care AUD -104900000 235.1M Dec/2024
Regis Healthcare AUD 24.36M 33.63M Dec/2024
ResMed USD 379.7M 35.08M Jun/2025
Sigma Healthcare AUD 3.72M 10.44M Jul/2024
Sonic Healthcare AUD 236.68M 82.29M Dec/2024
Telix Pharmaceuticals AUD 10.13M 19.52M Dec/2024